Technical Analysis for ACRV - Acrivon Therapeutics, Inc.

Grade Last Price % Change Price Change
F 6.50 1.88% 0.12
ACRV closed up 1.88 percent on Wednesday, November 20, 2024, on 33 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness 1.88%
Wide Bands Range Expansion 1.88%
Below Lower BB Weakness 1.88%
Oversold Stochastic Weakness 1.88%
MACD Bearish Centerline Cross Bearish 3.67%

   Recent Intraday Alerts

Alert Time
Rose Above Lower Bollinger Band about 21 hours ago
Up 1% about 21 hours ago
Up 3% 2 days ago
Fell Below Previous Day's Low 2 days ago
Down 2 % 2 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops precision oncology medicines. The company's lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1/2 for use in the treatment of platinum-resistant ovarian cancer; endometrial and bladder cancer; and SCCs, including SCCHN, cervical, and anal cancer. It is also developing two preclinical drug programs used to predict tumor sensitivity based on custom OncoSignature tests. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Oncology Tumor Ovarian Cancer Bladder Cancer Gynaecological Cancer Anal Cancer

Is ACRV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.9
52 Week Low 3.19
Average Volume 92,698
200-Day Moving Average 7.36
50-Day Moving Average 7.64
20-Day Moving Average 7.82
10-Day Moving Average 7.57
Average True Range 0.46
RSI (14) 32.43
ADX 28.82
+DI 16.13
-DI 32.80
Chandelier Exit (Long, 3 ATRs) 7.35
Chandelier Exit (Short, 3 ATRs) 7.50
Upper Bollinger Bands 9.21
Lower Bollinger Band 6.44
Percent B (%b) 0.02
BandWidth 35.31
MACD Line -0.28
MACD Signal Line -0.05
MACD Histogram -0.2331
Fundamentals Value
Market Cap 144.26 Million
Num Shares 22.2 Million
EPS -2.26
Price-to-Earnings (P/E) Ratio -2.88
Price-to-Sales 0.00
Price-to-Book 0.57
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.00
Resistance 3 (R3) 6.99 6.82 6.91
Resistance 2 (R2) 6.82 6.69 6.82 6.88
Resistance 1 (R1) 6.66 6.62 6.74 6.67 6.86
Pivot Point 6.49 6.49 6.53 6.49 6.49
Support 1 (S1) 6.33 6.36 6.41 6.34 6.14
Support 2 (S2) 6.16 6.29 6.16 6.12
Support 3 (S3) 6.00 6.16 6.09
Support 4 (S4) 6.01